Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Guide Médicaments is a French drug information lookup website operated by Yalta Production. Based on the scraped page content, it primarily publishes official opinions from France’s Haute Autorité de Santé (HAS) Transparency Committee on medicines’ Service Médical Rendu (SMR) and Amélioration du Service Médical Rendu (ASMR) since 2002, with the site showing a total of 15846 evaluations. Strictly speaking, it is not a typical SaaS or enterprise software product; it is closer to a public drug database and information directory.
The site offers an alphabetical index, a list of the latest drug evaluations, and individual drug detail pages. Detail pages include the drug name, laboratory, dosage form, packaging, market launch date, price, reimbursement rate, selected annual sales and reimbursement amounts, with a particular focus on SMR and ASMR assessments. SMR is used to determine the medical value of a drug itself and whether it is sufficient to support reimbursement, while ASMR describes the additional improvement compared with existing treatment options. This makes it useful as a reference for researching French drug reimbursement, clinical value assessment, and market access.
The scraped content does not show any subscription plans, enterprise edition, paid API, or trial mechanism, and the pages appear to be publicly accessible for free. There is also no information about team collaboration, role-based permissions, third-party integrations, webhooks, SDKs, bulk export, or developer support. Therefore, by SaaS standards, its enterprise capabilities are clearly limited. It is better suited as a web-based reference source than as a data platform that can be embedded into business workflows.
Its strengths are that the information points to official HAS evaluations, the data fields are centered on drug reimbursement and clinical value, and the structure is relatively stable. It also has long historical coverage and includes recent evaluations from 2026. Its drawbacks are that the interface feels like a traditional directory site, with limited interaction and filtering capabilities; some text appears to have encoding issues; for data security and compliance, only entries for personal data, cookies, and legal notices are visible, with no detailed measures found; and there is no evident internationalization or Chinese-language support.
It is suitable for researchers, pharmaceutical market access teams, and medical information users who follow French drug policy, health insurance reimbursement, and drug value assessment. It is less suitable for SaaS users who need enterprise-grade permissions, automated integrations, and structured APIs. The scraped text does not make it possible to determine access conditions from China, and there is no information about payment methods. For local Chinese alternatives, consider platforms such as 药智数据 and 米内网; for official French sources, you can directly consult HAS, ANSM, or the French public drug database.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on guide-medicaments.com official site.
guide-medicaments.com is an France Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach guide-medicaments.com directly.